Literature DB >> 16434574

Indoxyl sulfate induces complex redox alterations in mesangial cells.

Andrew K Gelasco1, John R Raymond.   

Abstract

Indoxyl sulfate is a protein metabolite that is concentrated in the serum of patients with chronic renal insufficiency. It also is a uremic toxin that has been implicated in the progression of chronic renal disease in rodent models. We have shown previously that mesangial cell redox status is related to activation of mitogen-activated protein kinases and cell proliferation, which are factors related to glomerular damage. We used three methods to examine the ability of indoxyl sulfate to alter mesangial cell redox as a possible mechanism for its toxicity. Indoxyl sulfate increases mesangial cell reduction rate in a concentration-dependent manner as demonstrated by redox microphysiometry. Alterations occurred at concentrations as low as 100 microM, with more marked alterations occurring at higher concentrations associated with human renal failure. We demonstrated that indoxyl sulfate induces the production of intracellular reactive oxygen species (ROS) in mesangial cells (EC50 = 550 microM) by using the ROS-sensitive fluorescent dye CM-DCF. ROS generation was only partially (approximately 50%) inhibited by the NADPH oxidase inhibitor diphenylene iodinium at low (< or = 300 microM) indoxyl sulfate concentrations. Diphenylene iodinium was without effect at higher concentrations of indoxyl sulfate. We also used electron paramagnetic spin resonance spectroscopy with extracellular and intracellular spin traps to show that indoxyl sulfate increases extracellular SOD-sensitive O2-* production and intracellular hydroxyl radical production that may derive from an initial O2-* burst. These results document that indoxyl sulfate, when applied to renal mesangial cells at pathological concentrations, induces rapid and complex changes in mesangial cell redox.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434574     DOI: 10.1152/ajprenal.00281.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  26 in total

1.  A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction.

Authors:  Ran-Hui Cha; Shin Wook Kang; Cheol Whee Park; Dae Ryong Cha; Ki Young Na; Sung Gyun Kim; Sun Ae Yoon; Sang Youb Han; Jae Hyun Chang; Sue K Park; Chun Soo Lim; Yon Su Kim
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 8.237

2.  Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.

Authors:  Hideyuki Saito; Misato Yoshimura; Chika Saigo; Megumi Komori; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Ayaka Wakida; Erina Chuman; Kazuhiko Nishi; Hirofumi Jono
Journal:  Toxicol Sci       Date:  2014-06-23       Impact factor: 4.849

3.  Dihydroartemisinin inhibits indoxyl sulfate (IS)-promoted cell cycle progression in mesangial cells by targeting COX-2/mPGES-1/PGE2 cascade.

Authors:  Harr-Keshauve Mungun; Shuzhen Li; Yue Zhang; Songming Huang; Zhanjun Jia; Guixia Ding; Aihua Zhang
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

Review 4.  Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.

Authors:  Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

5.  Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study.

Authors:  Eiichi Sato; Atsushi Tanaka; Jun-Ichi Oyama; Ayumu Yamasaki; Mitsuhiro Shimomura; Atsushi Hiwatashi; Yoshihiko Ueda; Mayuko Amaha; Mayumi Nomura; Daisuke Matsumura; Tsukasa Nakamura; Koichi Node
Journal:  Heart Vessels       Date:  2015-12-23       Impact factor: 2.037

6.  Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Authors:  Masahiro Kusumoto; Hiroki Kamobayashi; Daisuke Sato; Megumi Komori; Misato Yoshimura; Akinobu Hamada; Yukimasa Kohda; Kimio Tomita; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

7.  Evidence for Indoxyl Sulfate as an Inducer of Oxidative Stress in Patients With Diabetes.

Authors:  Ichiro Wakabayashi; Mikio Marumo
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

8.  From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.

Authors:  Milena B Stockler-Pinto; Christophe O Soulage; Natália A Borges; Ludmila F M F Cardozo; Carla J Dolenga; Lia S Nakao; Roberto Pecoits-Filho; Denis Fouque; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2017-11-18       Impact factor: 2.370

9.  Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells.

Authors:  Kyoji Moriya; Hideyuki Miyoshi; Takeya Tsutsumi; Seiko Shinzawa; Hajime Fujie; Yoshizumi Shintani; Hiroshi Yotsuyanagi; Kohji Moriishi; Yoshiharu Matsuura; Tetsuro Suzuki; Tatsuo Miyamura; Kazuhiko Koike
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

10.  p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

Authors:  I-Wen Wu; Kuang-Hung Hsu; Chin-Chan Lee; Chiao-Yin Sun; Heng-Jung Hsu; Chi-Jen Tsai; Chin-Yuan Tzen; Yen-Chih Wang; Ching-Yuang Lin; Mai-Szu Wu
Journal:  Nephrol Dial Transplant       Date:  2010-09-29       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.